International Consensus Statement on Platelet Function and Genetic Testing in Percutaneous Coronary Intervention
Dominick J. Angiolillo(University of Florida), Dirk Sibbing(Ludwig-Maximilians-Universität München), Jurriën M. ten Berg(St. Antonius Ziekenhuis), Naveen L. Pereira(Mayo Clinic), Deepak L. Bhatt(Mount Sinai Hospital), Udaya S. Tantry(Sinai Hospital), Dániel Aradi(HUN-REN Balaton Limnological Research Institute), José Luis Ferreiro(Institut d'Investigació Biomédica de Bellvitge), Roxana Mehran(Mount Sinai Hospital), Dimitrios Alexopoulos(Hygeia Hospital), Francesco Franchi(Florida College), Fabiana Rollini(Florida College), Jolanta M. Siller‐Matula(Medical University of Vienna), Marco Valgimigli(University of Bern), Mattía Galli(Maria Cecilia Hospital), Robert F. Storey(University of Sheffield), Konstantinos D. Rizas(German Centre for Cardiovascular Research), Diana A. Gorog(University of Hertfordshire), Gregg W. Stone(Cardiovascular Institute of the South), Laurent Bonello(Assistance Publique Hôpitaux de Marseille), Young‐Hoon Jeong(Chung-Ang University Hospital), Rossella Marcucci(Ospedali Riuniti San Giovanni di Dio e Ruggi d'Aragona), Dietmar Trenk(Universitäts-Herzzentrum Freiburg-Bad Krozingen), Larisa H. Cavallari(University of Florida), Derek So(University of Ottawa), Davide Capodanno(University of Catania), Tobias Geisler(Imperial College London), Franz‐Josef Neumann(University of Freiburg), Thomas Cuisset(Hôpital de la Timone), Jean‐Philippe Collet(Inserm), Ron Waksman(Clinical Research Institute), Paul A. Gurbel(Sinai Hospital), C. Michael Gibson(Baim Institute for Clinical Research)
Cited by 93
Related Papers
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2007|6.7k
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k